Navigation Links
Study Shows Once-Yearly Reclast Better than Risedronate at Increasing Bone Mass in Patients With Osteoporosis Caused by Glucocorticoids
Date:4/11/2008

- Glucocorticoids, commonly known as steroids, widely used to treat inflammatory conditions but can increase the risk of osteoporotic fractures

with up to 50% of patients on long-term therapy at risk(1,2) - Study of more than 800 men and women shows higher bone mineral density

with Reclast than with risedronate, a current established therapy(3)

- Regulatory approval sought for treatment and prevention of

glucocorticoid-induced osteoporosis in US

EAST HANOVER, N.J., April 11 /PRNewswire/ -- New data show that a once-yearly infusion of Reclast(R) (zoledronic acid) Injection 5mg was significantly better than risedronate at increasing bone mass in patients with osteoporosis caused by glucocorticoids, commonly known as steroids(3). These medications are widely used to treat inflammatory conditions but can cause bone loss and osteoporosis(1).

Up to 50% of patients receiving long-term glucocorticoid therapy are at increased risk of fracture due to osteoporosis(2). Glucocorticoid-induced osteoporosis (GIO) is the most prevalent form of "secondary osteoporosis," which is characterized by low bone mass that results directly from specific diseases or medications(1).

Results of a clinical study in 833 men and women were presented today at the European Congress on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ECCEO) in Istanbul, Turkey(3).

"Recognizing and treating GIO is an important need, as glucocorticoid therapy is widely used and presents an ongoing challenge for physicians," said Professor David M. Reid, Head of the Division of Applied Medicine at University of Aberdeen, UK. "The significant efficacy of this once-yearly treatment, offering year-long bone protection, will provide a valuable treatment option for healthcare professionals treating and managing osteoporosis induced by glucocorticoids."

The trial investigated both prevention (n=288) and treatment (n=545)
'/>"/>

SOURCE Novartis Pharmaceuticals Corporation
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)... JOHANNESBURG, South Africa, Nov. 26 /PRNewswire/ ...any of the Year Award in the Generic Pharmaceutica... Limited. ,, (Logo: http://www.newscom.com/cgi...of the Year Award, the following criteria were use...key competitors: growth strategy and implementatio...
(Date:11/25/2009)...LOVELAND, Colo., Nov. 25 ...rovider of advanced diagnostic and specialty pro...agreements with Roche Diagnostics Corporation for ...nsumables for the veterinary market. ,, (Log...HESKALOGO ) ,, "Heska and Roche share the same ...
(Date:11/25/2009)..., PHILADELPHIA, Nov. 25 ...hael J. McKelvey, the Company,s President and CEO,...resident and CFO, are scheduled to present at the ...t 1:30 PM EST on December 1, 2009 in New York City...e presentation by visiting the Company,s corporate...
Breaking Medicine Technology:Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 2Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 3Frost & Sullivan Award Underlines Cipla Medpro's Status as Company of the Year in the South African Generic Pharmaceutical Market 4Heska Announces Supply Agreement With Roche Diagnostics 2Heska Announces Supply Agreement With Roche Diagnostics 3ERT to Present at the 21st Annual Piper Jaffray Health Care Conference on December 1, 2009 2Bay Medical Fights Healthcare Associated Infections by Improving Hand Hygiene 300 25 57427 1Bay Medical Fights Healthcare Associated Infections by Improving Hand Hygiene 300 25 57427 2Bay Medical Fights Healthcare Associated Infections by Improving Hand Hygiene 300 25 57427 3Bay Medical Fights Healthcare Associated Infections by Improving Hand Hygiene 300 25 57427 4Nielsen Announces First Ever CLIO Healthcare Awards Mixer on November 13th at Skyline Studios NYC 57425 1Nielsen Announces First Ever CLIO Healthcare Awards Mixer on November 13th at Skyline Studios NYC 57425 2Nielsen Announces First Ever CLIO Healthcare Awards Mixer on November 13th at Skyline Studios NYC 57425 3ClearWay Minnesota 28SM 29 Board Approves New Officers 57423 1ClearWay Minnesota 28SM 29 Board Approves New Officers 57423 2
...ug Represents Potential New Approach for the Treat... Disease Milestone Triggers $10 Million Payment ...f., May 13 ChemoCentryx, Inc., today,announced th..., an,orally-available, novel small molecule compou...ine receptor which is associated with inflammatory...
...loraPrep(R) Products Expand Infection Prevention B...,global provider of products and services that imp...oday announced it has completed the,acquisition of...acturer of,infection prevention products sold unde...and products are used widely in U.S. hospitals and...
Other Medicine Technology:ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 2ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 3ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 4ChemoCentryx Initiates Clinical Trial of CCR1 Inhibitor CCX354 5Cardinal Health Completes Enturia Acquisition 2
(Date:11/29/2009)...uot;The YogaForce A-Line Athletic Mat is great. I..., M.D., author and physician best known for establ...edicine. Go to www.yogaforce.com and order the ...ist. , San Francisco, CA ...holidays, the YogaForce newly patented, revolution...
(Date:11/28/2009)...elieved to affect circadian rhythm, , ...rch suggests that an internal body clock that goes... of bipolar disorder in children. , The findin...up of 152 children with bipolar disorder, which ca...d 140 children without the disorder. They linked v...
(Date:11/27/2009)... Considered a highly ris...rs ago, solid organ transplantation is now a life-...inary men and women who gathered at the Winspear O...ther from medical centers around the world to cele...splant Institute (BRTI), one of the pioneers of so...
(Date:11/27/2009)...naCare Holdings has announced that it has become a... of the largest nonprofit organizations dedicated ... , Delray Beach, FL (Vocu...TCBB: XCHO), a company specializing in the marketi...products, has announced today that is has become a...
(Date:11/27/2009)...lti-purpose bilingual coloring books designed for ...iness community to educate - inform parents and ch...issues to Dinosuars to ABC,S and a host of other t...(PRWEB) November 27, 2009 -- Today’s childre... them busy any hour of the day, but one of the old...
Breaking Medicine News(10 mins):Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 2Health News:The YogaForce A-Line Mat Provides The Perfect Solution For Fitness Needs 3Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 2Health News:Organ Transplant Pioneers Celebrate Baylor Regional Transplant Institute's 25th Anniversary 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 2Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 3Health News:XenaCare Holdings Announces National Sponsorship of the Arthritis Foundation 4Health News:Really Big Coloring Books Debuts Bi-Lingual Spanish-English Line of Custom and Imprintable Coloring Books 2
... have been seen in a wealth of scientific studies,...o a surprising observation – that high fish intake... stroke. // Fish Oil is one of the best sour...proved behavior of children with ADHD when their d...
...alternative shows a recent Consumer Reports survey...that Chiropractic was ranked ahead of all conventi...by readers with back pain. Deep-tissue massage was...re less effective than chiropractic and massage, o...
...ion of The Lancet Neurology says that the fact tha...ple sclerosis is nothing but a myth. Birth order o...ing the disease, nor does their family size // hav...arch has reported a higher risk of MS in offspring...
...of treating patients suffering from hypertension. ... indicate that the new drug is effective as a sing...complicated // essential high blood pressure. Resu...o the once-a-day oral medication. The evaluat...
...ate stem cells that resemble those of the embryoni...yonic state could eliminate the need for creation ... If future experiments are directed to ensure...uld theoretically be used to produce embryonic ste...
...regnancies have recently also been under intense s...t sexually transmitted diseases (e.g. Gonorrhea an...ondoms undoubtedly provide protection even the mos...that how much protection do they provide and how f...
Other Medicine News:Health News:A Latest Study Links Fish To Stroke 2Health News:Aliskiren: A New Treatment For Hypertension 2Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 2Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 3Health News:"An Armour against pleasure, and a cobweb against infection" – Has the condom withstood the test of time 4
Goat Anti-Mouse IgG Antibody, Gold Conjugated
Goat Anti-Human IgM Antibody, Gold Conjugated
Goat Anti-Human IgA, alpha chain Antibody, Colloidal Gold Conjugated, 50 OD
Protein A, Gold Ribbon - .13 OD per sq. cm.
Medicine Products: